Survivor | Jotup

Gacha Strategy Horror Game Launches as Generation Zombie

Retrieved on:

Thursday, March 14, 2024

RPG, Hygiene, Mechanics, Gravity Interactive, Mental, Discord, Gold, Survivor, Google Play, PvP, Language, Recruit, IOS, PVP, Android, Video game

BUENA PARK, Calif., March 13, 2024 /PRNewswire/ -- Gravity Interactive has officially launched its new strategy horror game, Generation Zombie. The strategy title went live on March 13th, 2024, with it being free-to-play via the Google Play and App Store. After a successful Android beta test in September of last year, the game has received a large round of content updates and changes. While the beta test offered in-game language support in English, Japanese and Korean, Generation Zombie will offer additional language support after the game launches. French, German, Spanish, Portuguese, traditional Chinese, and simplified Chinese will be added via future updates.

Key Points:

BUENA PARK, Calif., March 13, 2024 /PRNewswire/ -- Gravity Interactive has officially launched its new strategy horror game, Generation Zombie .
While the beta test offered in-game language support in English, Japanese and Korean, Generation Zombie will offer additional language support after the game launches.
It believes Generation Zombie offers a unique strategic playstyle, with mechanics and features that are not widely seen in the genre.
Generation Zombie fans can follow the game on Facebook to be informed about upcoming events, giveaways, updates and more.

United Breast Cancer Foundation Announces Powerful PSA Featuring Vivica A. Fox

Retrieved on:

Wednesday, March 13, 2024

Diagnosis, Breast cancer, Tears, Disease, Shock, Patient, United Breast Cancer Foundation, Life, Woman, Survivor, Vivica, PSA, Frustration, Shawn, Human, Birth control

HUNTINGTON STATION, N.Y., March 13, 2024 /PRNewswire-PRWeb/ -- United Breast Cancer Foundation (UBCF) announces the release of a moving and impactful public service announcement (PSA) featuring actress Vivica A. Fox. Debuting in select markets nationwide last month, the piece highlights UBCF's critical work in supporting individuals and families facing the challenges of breast cancer. View the 60 second and 120 second pieces on UBCF's YouTube channel.

Key Points:

HUNTINGTON STATION, N.Y., March 13, 2024 /PRNewswire-PRWeb/ -- United Breast Cancer Foundation (UBCF) announces the release of a moving and impactful public service announcement (PSA) featuring actress Vivica A.
The PSA opens with powerful testimonials from real UBCF clients, each sharing their raw and emotional struggles with breast cancer.
"United Breast Cancer Foundation is a group of strangers who cared for me when I was hurting in creative and very helpful, kind ways."
Stephanie Mastroianni, UBCF's Executive Director added, "United Breast Cancer Foundation is honored to have the support of Vivica A.

Anapol Weiss Acquires Fierce Philadelphia Litigator Who Prosecuted Bill Cosby and Won Two Eight-Figure Verdicts on the Same Day in 2023

Retrieved on:

Wednesday, March 13, 2024

MSNBC, Personal injury, The New York Times, Private practice, Temple University, Female, Human, Woman, Special Victims Unit, Survivor, Krissy, Instinct, MeToo movement, Nursing

PHILADELPHIA, March 13, 2024 /PRNewswire-PRWeb/ -- Kristen Gibbons Feden, one of America's most fierce and famous trial attorneys, has joined Philadelphia's Anapol Weiss to lead its sexual abuse and civil rights litigation practices. In 2018, Feden was hailed by The New York Times as "The Prosecutor Who Stared Down Bill Cosby." In 2023, Feden earned national recognition for winning two eight-figure verdicts in the same day – a $10.5M verdict for victims of rapper R. Kelly and a $22M verdict for the sexual abuse victim of a renowned pediatrician in New York.

Key Points:

PHILADELPHIA, March 13, 2024 /PRNewswire-PRWeb/ -- Kristen Gibbons Feden, one of America's most fierce and famous trial attorneys, has joined Philadelphia's Anapol Weiss to lead its sexual abuse and civil rights litigation practices.
In 2018, Feden was hailed by The New York Times as "The Prosecutor Who Stared Down Bill Cosby."
Prior to joining Anapol Weiss, Feden sharpened her legendary skills through both private practice and as a prosecutor.
"We are thrilled Krissy is joining our family of exceptional trial lawyers at Anapol Weiss," said Managing Shareholder, Thomas Anapol.

More Than Two Dozen Former Residents of Good Shepherd Services Allege Sexual Abuse by Nuns, Priests and Staff at Notorious Youth Residential Treatment Facility

Retrieved on:

Tuesday, March 12, 2024

BALTIMORE, March 12, 2024 /PRNewswire/ -- The State of Maryland, Maryland Department of Juvenile Services, Maryland Department of Human Services and Maryland Department of Health are being named in a civil lawsuit today alleging that at least 26 individuals were sexually assaulted as children while housed at Good Shepherd Services, a former residential facility for foster care youth. The lawsuit was filed in the Maryland Circuit Court for Baltimore City by attorneys at Slater Slater Schulman LLP, a leading, full-service law firm with decades of experience representing survivors of traumatic and catastrophic events.

Key Points:

Originally opened in 1864, Good Shepherd Services operated until 2017 as a multi-use, state-run residential treatment facility for children in Halethorpe, MD.
It housed children with behavioral health issues, as well as foster care youth sent through the Department of Human Services.
It also served as a secure facility for children sentenced to correctional incarceration through the Department of Juvenile Services.
The abuses at Good Shepherd Services were first reported on by The Baltimore Sun in 2013.

Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society's Light The Night

Retrieved on:

Tuesday, March 12, 2024

"BeiGene is proud to expand our partnership with the Leukemia and Lymphoma Society this year as the National Presenting Sponsor of Survivorship and Hope for Light The Night," Josh Neiman, Chief Commercial Officer at BeiGene, said.

Key Points:

"BeiGene is proud to expand our partnership with the Leukemia and Lymphoma Society this year as the National Presenting Sponsor of Survivorship and Hope for Light The Night," Josh Neiman, Chief Commercial Officer at BeiGene, said.
"LLS's Light The Night inspires communities, bringing more people out of the darkness of cancer, shining a light on survivors everywhere.
BeiGene has been supporting LLS's Light The Night for the past five years, and before becoming the National Presenting Sponsor of Survivorship and Hope, was a Light The Night National Sponsor in 2022 and 2023.
To join Light The Night and shine a light on survivorship and hope, visit www.lightthenight.org .

United Breast Cancer Foundation Uplifts Those Facing Breast Cancer at Huntington Station Spring Pink Bag Event

Retrieved on:

Monday, March 11, 2024

Research, Dopamine, Hormone, Serotonin, Rejuvenation, Incidence, Patient, Sleep, United Breast Cancer Foundation, Shoe, Woman, Survivor, Empowerment, Happiness, System, Breast cancer, Oxytocin, Online shopping

HUNTINGTON STATION, N.Y., March 11, 2024 /PRNewswire-PRWeb/ -- United Breast Cancer Foundation (UBCF) is excited to announce the highly anticipated return of its Spring Pink Bag Event to its Huntington Station headquarters. Taking place from Saturday, March 23rd to Wednesday, March 27th, 2024, this individualized, free "shopping" event promises to fill hearts and Pink Bags with a touch of spring cheer for breast cancer patients and survivors.

Key Points:

HUNTINGTON STATION, N.Y., March 11, 2024 /PRNewswire-PRWeb/ -- United Breast Cancer Foundation (UBCF) is excited to announce the highly anticipated return of its Spring Pink Bag Event to its Huntington Station headquarters.
Embrace the spirit of renewal and rejuvenation by joining UBCF for the Spring Pink Bag Event.
UBCF is committed to supporting individuals facing this challenge, and the Spring Pink Bag Event aims to alleviate some burdens and bring joy and comfort to individuals facing breast cancer.
Learn more about UBCF's Spring Pink Bag Event and submit your eligibility form today at https://www.ubcf.org/march-2024-ny-pbe/

Federal Ombudsperson launches systemic investigation into treatment of survivors of sexual assault in Canadian Justice System

Retrieved on:

Monday, March 11, 2024

Pillar, Office, Public security, National security, Woman, Minister, Survivor, Law enforcement, Research, Bill of Rights, Gender equality, Justice, Access, Victim, Private investigator

OTTAWA, ON, March 11, 2024 /CNW/ - The Office of the Federal Ombudsperson for Victims of Crime (OFOVC) announces the launch of a systemic investigation on the experiences of survivors of sexual assault within the Canadian criminal justice system.

Key Points:

OTTAWA, ON, March 11, 2024 /CNW/ - The Office of the Federal Ombudsperson for Victims of Crime (OFOVC) announces the launch of a systemic investigation on the experiences of survivors of sexual assault within the Canadian criminal justice system.
Dr. Benjamin Roebuck, Federal Ombudsperson for Victims of Crime, underscored the imperative for change, stating, "The treatment of survivors of sexual assault within Canada's criminal justice system demands urgent improvement.
We have normalized the idea that the criminal justice system will be a painful experience for survivors of sexual violence."
The investigation will cover survivors' interactions with law enforcement and the justice system from the point of initial contact through to post-sentencing.

Noma is a truly devastating tropical disease – more people need to know about it

Retrieved on:

Wednesday, April 3, 2024

Eating, Finger, Stigmata, Face, Cheek, Disease, Infection, Patient, Research, Social isolation, Food, Nature, Life, Poverty, Eye, Drinking, Survivor, Mone, Mouth, Water, WHO, Nose, Family, Swelling, Vaccine

In December 2023, after years of advocacy, noma was finally included on the World Health Organization’s list of “neglected tropical diseases”.

Key Points:

In December 2023, after years of advocacy, noma was finally included on the World Health Organization’s list of “neglected tropical diseases”.
Mone is a noma survivor from Laos, and her experience of noma is typical of so many who have suffered from this disease.
Quickly, her cheek skin fell away and teeth and bones started coming out of the sore in her cheek.
The healthcare workers, her family and the villagers did not know why Mone suffered and suspected that ghosts were punishing her.
However, if they are given widely available antibiotics in these early stages, the infection can be halted, and the patient saved.

Much remains a mystery

Noma is an ancient disease, with the earliest description being found in a medical textbook from the first century. It was often seen in Europe up until the 1800s, but has all but disappeared due to better access to food, water and healthcare. Now noma only affects the very poorest communities in the world.

We know it is bacterial in nature, but we haven’t been able to identify the causative organisms.
We know it’s not infectious, but do not understand why some children get it while other children living in the same conditions do not.
And will provide a much-needed impetus for governments and health agencies to work together to help patients and survivors.

Stuart Ainsworth is currently lead researcher on a noma project funded by Médecins Sans Frontières, and is affiliated with The International Noma Network.

APPLICATIONS OPEN FOR FISHER SERVICE AWARD FOR MILITARY COMMUNITY SERVICE

Retrieved on:

Thursday, March 7, 2024

Spouse, Fisher House Foundation, Quality of life, Transport, Sightline Media Group, Bath, Tragedy, Advertising, Survivor, Veteran

Rockville, MD, March 07, 2024 (GLOBE NEWSWIRE) -- Fisher House Foundation is accepting applications for the Fisher Service Award that recognizes and supports other nonprofits serving the military and veteran communities.

Key Points:

Rockville, MD, March 07, 2024 (GLOBE NEWSWIRE) -- Fisher House Foundation is accepting applications for the Fisher Service Award that recognizes and supports other nonprofits serving the military and veteran communities.
Fisher House Foundation and Military Times Foundation will award $250,000 to innovative programs enhancing the quality of life for service members, veterans, and their families.
The Fisher Service Award replaced the long-running Newman’s Own Award Program.
As part of the award package, recipients of the Fisher Service Award will each also receive an advertising package valued at $50,000 from Military Times.

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Retrieved on:

Monday, March 4, 2024

Level 2, Survivor, CMS, Helios, ATM, Sale, Stroke, Multiple sclerosis, Pons, Medicare, HSDT, Walking, DSM-IV codes, HCPCS, Health insurance

NEWTOWN, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (“CMS”) has assigned Healthcare Common Procedure Coding System (“HCPCS”) Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece. The new HCPCS codes will be effective April 1, 2024.

Key Points:

The new HCPCS codes will be effective April 1, 2024.
“PoNS Therapy® is life-changing for people who suffer gait impairment due to MS and we’re pleased that CMS understood the benefits of this innovative treatment by establishing HCPCS codes for both the PoNS mouthpiece and controller.
This marks a critical reimbursement and access milestone and provides Helius the ability to begin negotiating reimbursement with third-party payers using these unique HCPCS codes.
In Canada, PoNS is authorized to treat balance impairment due to MS, stroke and mild-to-moderate traumatic brain injury.